On February 27th, The Wall Street Journal reported that Altria Group (MO.N) is in talks to acquire US third largest e-cigarette brand, NJOY, for $2.75 billion, citing anonymous sources. It is reported that NJOY has received PMTA approval from FDA for a total of 6 products.
The outcome of this transaction could be announced as early as this week, but reports suggest that there is still a possibility of failure in the negotiations.
List of PMTA-approved products in 2022 | Source: FDA2FIRSTS will continue to follow this report, stay tuned.
Reference(s):
Cigarette manufacturer Altria is currently negotiating to purchase vaping startup NJOY for a minimum of $2.75 billion. As part of this deal, Altria is also planning to sell its existing shares in Juul.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
